zoledronic acid has been researched along with AL Amyloidosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conca, P; Di Minno, G; Matani, B; Rendina, D; Tufano, A | 1 |
1 other study(ies) available for zoledronic acid and AL Amyloidosis
| Article | Year |
|---|---|
Hypocalcemia and hypophosphatemia after treatment with zoledronic acid in a patient with AL amyloidosis.
Topics: Administration, Intravenous; Bone Density Conservation Agents; Fatigue; Humans; Hypocalcemia; Hypophosphatemia; Immunoglobulin Light-chain Amyloidosis; Male; Middle Aged; Zoledronic Acid | 2019 |